These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 9507284)

  • 1. [Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case].
    Beji M; Louzir B; Ben Rhomdane N; Zouari M; Mtimet B; Daghfous J
    Tunis Med; 1995 May; 73(5):201-3. PubMed ID: 9507284
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of thrombocytopenia caused by rifampicin and pyrazinamide.
    Bansal R; Sharma PK; Sharma A
    Indian J Pharmacol; 2013; 45(4):405-7. PubMed ID: 24014922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
    Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
    Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid oral tolerance induction to isoniazid and pyrazinamide and controlled administration of ethambutol: clinical case.
    Rodrigues Carvalho S; Silva I; Leiria-Pinto P; Rosado-Pinto J
    Allergol Immunopathol (Madr); 2009; 37(6):336-8. PubMed ID: 19875222
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of drug-resistant tuberculosis.
    Lester W
    Dis Mon; 1971 Apr; ():1-43. PubMed ID: 4327834
    [No Abstract]   [Full Text] [Related]  

  • 9. [Procedure in case of suspected mycobacterial infection of lymph nodes of the neck. 2. Therapy].
    Göpel B; Götte K
    Laryngorhinootologie; 2005 Aug; 84(8):610-9; quiz 621-2. PubMed ID: 16080064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short-course chemotherapy of tuberculosis with pyrazinamide].
    Asai S; Futsuki Y; Tomari S; Araki J
    Nihon Rinsho; 1998 Dec; 56(12):3087-90. PubMed ID: 9883615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of antituberculosis drugs.
    Girling DJ
    Drugs; 1982; 23(1-2):56-74. PubMed ID: 6459920
    [No Abstract]   [Full Text] [Related]  

  • 12. Side effects of rifampicin. A clinical study.
    Mattson K
    Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
    [No Abstract]   [Full Text] [Related]  

  • 13. [Internal medicine treatment of pulmonary tuberculosis].
    Schaich W
    Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of thrice-weekly rifampicin for tuberculosis in South-East Asian refugees.
    Mukerjee CM; McKenzie DK
    Aust N Z J Med; 1985 Apr; 15(2):226-9. PubMed ID: 3861165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombocytopenia induced by rifampicin not previously sensitized: a case presentation].
    Neino Mourtala Mohamed A; Tummino C; Gouitaa M; Chanez P
    Rev Mal Respir; 2013 Nov; 30(9):785-8. PubMed ID: 24267770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proceedings: Rifampicin adverse effects in intermittent therapy].
    Herrmann H; Eule H; Lau W; Kuhnert R; Fanter D; Kahlau U; Schönert E; Werner E
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):146-58. PubMed ID: 4491712
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampin-induced severe thrombocytopenia in a patient with pulmonary tuberculosis.
    Kindelán JM; Serrano I; Jurado R; Villanueva JL; García-Lázaro M; García-Herola A; Torre Cisneros J
    Ann Pharmacother; 1994 Nov; 28(11):1304-5. PubMed ID: 7849351
    [No Abstract]   [Full Text] [Related]  

  • 18. Antituberculosis agents.
    Goldberger MJ
    Med Clin North Am; 1988 May; 72(3):661-8. PubMed ID: 3280912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of tuberculosis for patients with renal impairment.
    Ellard GA
    Nephron; 1993; 64(2):169-81. PubMed ID: 8321347
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.